Therapeutic Vaccine Equipment
-
Manufactured by ORYX GmbH & Co. KGbased in GERMANY
of HR-HPV-mediated cell transformation. About 5% of all cancers are associated with HR-HPV including virtually all cervical cancers, 85-95% of anal and vulvar cancers, 20-40% of vaginal and penile cancers and 30-60% of head and neck cancers. Currently, two prophylactic vaccines are on the market that induce HPV-type specific protective immunity but ...
-
Manufactured by ORYX GmbH & Co. KGbased in GERMANY
Several cancers arise from the lack of DNA mismatch repair (MMR) resulting in the accumulation of thousands of single deletions or insertions at coding microsatellites (MSI-H). These mutations lead to the inactivation of specific proteins and to the expression of frameshift peptides (FSPs). These FSPs are tumor-specific antigens, which are constantly expressed. Cancers with MSI-H mutations ...
-
Manufactured by Transgenebased in FRANCE
TG4001 is an innovative therapy capable of combating papillomavirus-induced cancers. The concept behind TG4001 is to teach the immune system to recognise and destroy the cancer cells expressing HPV-16 antigens, specifically E6 and E7 ...
-
based in BELGIUM
The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...
-
Manufactured by Transgenebased in FRANCE
A particularly innovative immunotherapy, TG4050 is the lead myvac® candidate. This individualized treatment is based on the specific mutations that are identified in each patient’s ...
-
Manufactured by Gritstone Biobased in USA
We have a collaboration established with Gilead Sciences to research and develop a vaccine-based immunotherapy as part of Gilead’s efforts to cure patients with human immunodeficiency virus (HIV) infection. The companies are developing an HIV-specific therapeutic vaccine using Gritstone’s proprietary prime-boost ...
-
Manufactured by VBI Vaccines Inc.based in USA
protein antigen, including multiple antibody and T cell targets, making them ideal technologies for the development of both prophylactic and therapeutic vaccines. Moreover, most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them prime targets for VBI’s proprietary enveloped ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines is developing a GeneVav prime/VesiculoVax™ boost therapeutic vaccine that targets all HCV genotypes for use as an adjunct to drug ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic vaccine for herpes simplex virus type-2. This vaccine is designed to ameliorate disease and transmission by preventing HSV-2 reactivation and ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
-
Manufactured by Auro Vaccines LLCbased in USA
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic HPV vaccine for use as an adjunct to surgery that targets the seven HPV types responsible for more than 92% of cervical and head and neck ...
-
Manufactured by Vitruvian BioMedical, Inc.based in USA
VITRUVIAN has obtained the Exclusive Global License for a Therapeutic Vaccine for the Prevention of Alzheimer's Disease. YM7555 - Alzheimer’s Disease Therapeutic Vaccine targeting ABeta and TAU. VITRUVIAN has received an Exclusive Global License for YM7555 which is a Therapeutic Vaccine ...
-
Manufactured by ViciniVax BVbased in NETHERLANDS
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first clinical trial, which has been started in ...
-
Manufactured by Enteromebased in FRANCE
OncoMimicsTM vaccines are a specific combination of bacterial peptides, derived from bacteria present in the gut microbiome, that closely mimic either overexpressed tumor-associated antigens (TAAs) or lineage-specific markers in solid and liquid tumors, respectively. ...
-
Manufactured by Frontier Biotechnologies Inc.based in CHINA
Licensed with exclusive rights for greater China from AFFiRiS AG, a clinical-stage biotechnology company in Austria, FB6001 is an investigational therapeutic peptide vaccine targeting PCSK9 to treat hypercholesterolemia. PCSK9 is a clinically validated target and FB6001 is a potential first-in-class immunotherapy for hypercholesteremia. ...
-
Manufactured by Enteromebased in FRANCE
EO4010 is an innovative, off-the-shelf therapeutic cancer vaccine currently in discovery. EO4010 peptides combination will include two OncoMimics (bacterial peptides) already used in EO2401 and one or two additional peptides in an indication with high unmet medical need and market potential. ...
-
Manufactured by Enteromebased in FRANCE
EO2463 is an innovative, off-the-shelf therapeutic cancer vaccine discovered by Enterome. EO2463 combines four OncoMimics peptides (bacterial peptides) of B lymphocyte-specific lineage markers. The clinical rationale behind targeting these specific lineage cell markers is to induce the full depletion of malignant B lymphocytes enriched in ...
-
Manufactured by Chimeron Biobased in USA
Self-amplifying RNA (saRNA) replicon is a type of RNA genome that is unique to certain families of viruses. This highly specialized system lets the virus make multiple copies of its RNA genome, and therefore encoded proteins, from just a single RNA template. ...
-
Manufactured by Enteromebased in FRANCE
EO2401 is an innovative, off-the-shelf immunotherapy discovered by ...
-
Manufactured by NightHawk Biosciencesbased in USA
Recent advancements in immunotherapies demonstrate the promise of harnessing the body’s immune system to combat complex diseases. Our proprietary gp96 platform leverages the immune stimulatory properties of the heat shock protein gp96 to induce the immune system’s own response against cancer and infectious disease. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you